Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Horina, J. H.
Right arrow Articles by Krejs, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horina, J. H.
Right arrow Articles by Krejs, G. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (1993) 8: 1219-1222
© 1993 European Renal Association-European Dialysis and Transplant Association

research-article

Increased red cell 2,3-diphosphoglycerate levels in haemodialysis patients treated with erythropoietin

J. H. Horina1,, G. Schwaberge2, H. Brussee1, G. Sauseng-Fellegger2, H. Holzer1 and G. J. Krejs1

1Departments of Medicine, Karl Franzens University Graz, Austria 2Departments of Physiology, Karl Franzens University Graz, Austria

Correspondence and offprint requests to: Correspondence and offprint requests to: Jörg H. Horina MD, Department of Medicine, Karl Franzens University, Auenbmggerplatz 15, A-8036 Graz, Austria

The efficacy of recombinant human erythropoietin (rHuEpo) for the treatment of renal anaemia is well established. To assess the effect of rHuEpo treatment on physical performance we evaluated physical working capacity, oxygen uptake and red cell 2,3diphosphoglycerate (DPG) values at rest and during and after exercise on a bicycle spiroergometer in eight chronically haemodialysed patients. Follow-up examination was carried out after a mean of 14 weeks (range 9–19 weeks), when mean haemoglobin had increased from 7.8 to a stable value of 13.0 g/dl in response to rHuEpo treatment (P<0.001). Physical working capacity and oxygen uptake at the anaerobic threshold (4 rnrnol/l blood lactate concentration) increased from 68±12 to 80±16 watts and 0.95±0.14 to 1.10±0.20 l/min, respectively (P<0.01). DPG, which determines oxygen affinity to haemoglobin in red cells, increased by 13% from 13.7±1.5 to 15.5±2.2 pmol/g Hb (P<0.05 ). With maximal exercise mean DPG values significantly decreased to a much lower level without rHuEpo treatment than after correction of anaemia. Therefore rHuEpo treatment results both in better oxygen transport capacity and reduced intraerythrocytic oxygen affinity, which is followed by improved oxygen delivery to tissues per unit of haemoglobin. These effects may explain the improvement of exercise capacity observed in dialysis patients after rHuEpo treatment.

Keywords: anaemia; 2,3-diphosphoglycerate; erythropoietin; haemodialysis; physical performance


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.